Echocardiographic Assessment and Clinical Applications of the Left Atrial Stiffness Index in Cardiovascular Disease
- 1The Second Affiliated Hospital of Shenyang Medical College
Abstract
The left atrial stiffness index is an emerging echocardiographic marker that integrates pressure-related burden and atrial reservoir deformation to provide a composite measure of left atrial pressure-deformation coupling. This review summarizes the pathophysiological basis of left atrial stiffness, the methodological principles underlying echocardiographic left atrial stiffness index assessment, and the current evidence supporting its clinical applications across cardiovascular diseases. The strongest evidence is available in heart failure and atrial fibrillation, in which increased left atrial stiffness index has been associated with adverse hemodynamics, exercise intolerance, rhythm recurrence, and adverse clinical outcomes. In hypertension, cardiomyopathies, valvular heart disease, and congenital or aortic disorders, available data suggest potential clinical relevance, although the evidence remains more heterogeneous and less mature; by contrast, evidence in ischemic, inflammatory, and stroke-related settings is still preliminary. Despite its physiological appeal, broader clinical adoption remains limited by methodological heterogeneity, variable thresholds, limited invasive validation, and uncertain incremental value beyond its component measures. At present, left atrial stiffness index is best positioned as an adjunctive marker for phenotyping, hemodynamic assessment, and risk stratification, particularly in heart failure and atrial fibrillation, pending further methodological harmonization and prospective disease-specific validation.
Related
- Shear-Wave Elastography in Musculoskeletal Pain: Current Evidence and Clinical Applications for Tissue Stiffness Assessment
- Clinical and Echocardiographic Characterization of Stage B Heart Failure in Asymptomatic Adults With Cardiovascular Risk Factors.
- Echocardiographic markers for left atrial stiffness and left atrial conduction delay in patients with silent paroxysmal atrial fibrillation compared to age-matched controls.
- Subclinical Cardiovascular Adaptation in Uncomplicated Monochorionic Twin Pregnancies: Echocardiographic and Cardiac Biomarker Findings
- Deep-Learning-Based Assessment of Breast Arterial Calcification on Mammography: Technical Validation, Cardiovascular Prognostic Value, and Clinical Translation—A Narrative Review
BibTeX
@article{liu2026echocardiographic,
title = {{Echocardiographic Assessment and Clinical Applications of the Left Atrial Stiffness Index in Cardiovascular Disease}},
author = {Xu Liu and Haomeng Xu and Yan Tong and Ying Ding and Shuai Wang},
journal = {Journal of the American Heart Association},
year = {2026},
month = oct,
doi = {10.1161/jaha.126.051787},
url = {https://www.ahajournals.org/doi/10.1161/JAHA.126.051787},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Echocardiographic Assessment and Clinical Applications of the Left Atrial Stiffness Index in Cardiovascular Disease
AU - Xu Liu
AU - Haomeng Xu
AU - Yan Tong
AU - Ying Ding
AU - Shuai Wang
PY - 2026
DA - 2026/10/20
JO - Journal of the American Heart Association
DO - 10.1161/jaha.126.051787
UR - https://www.ahajournals.org/doi/10.1161/JAHA.126.051787
AB - The left atrial stiffness index is an emerging echocardiographic marker that integrates pressure-related burden and atrial reservoir deformation to provide a composite measure of left atrial pressure-deformation coupling. This review summarizes the pathophysiological basis of left atrial stiffness, the methodological principles underlying echocardiographic left atrial stiffness index assessment, and the current evidence supporting its clinical applications across cardiovascular diseases. The strongest evidence is available in heart failure and atrial fibrillation, in which increased left atrial stiffness index has been associated with adverse hemodynamics, exercise intolerance, rhythm recurrence, and adverse clinical outcomes. In hypertension, cardiomyopathies, valvular heart disease, and congenital or aortic disorders, available data suggest potential clinical relevance, although the evidence remains more heterogeneous and less mature; by contrast, evidence in ischemic, inflammatory, and stroke-related settings is still preliminary. Despite its physiological appeal, broader clinical adoption remains limited by methodological heterogeneity, variable thresholds, limited invasive validation, and uncertain incremental value beyond its component measures. At present, left atrial stiffness index is best positioned as an adjunctive marker for phenotyping, hemodynamic assessment, and risk stratification, particularly in heart failure and atrial fibrillation, pending further methodological harmonization and prospective disease-specific validation.
SN - 2047-9980
ER -